Brokers bullish on Aurobindo Pharma shares

The Aurobindo Pharma (NSI:AUROPHARMA) share price has risen by 12.7% over the past month and it’s currently trading at 865.75. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Aurobindo Pharma currently has:

• 16 Buy recommendations

• 3 Hold recommendations

• 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO NSI:AUROPHARMA »

Researching beyond analyst forecasts

At its current price of 865.75, shares in Aurobindo Pharma are trading at a discount of -0.73% to its 52 week high price. The 1-year performance of the shares has been 58.8%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Aurobindo Pharma it's worth doing some investigation yourself.

There are all sorts of factors that could affect Aurobindo Pharma's share price this year – we simplify them into easy to understand scores with our Stockopedia StockReport. Click here to take a look at the StockReport for Aurobindo Pharma – you might discover some surprising things you didn’t know.